| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215697 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 8 Pages |
Abstract
Our phase 2 institutional study offers one of the shortest courses of HF therapy, delivered in 15 fractions inclusive of a sequential boost. We demonstrated expected low toxicity and high local control rates with good to excellent cosmetic outcomes. This fractionation scheme is feasible and well tolerated and offers women WBI in a highly convenient schedule.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Stuti MD, Bruce G. MD, Sharad MD, Thomas MD, Laurie MD, Chunxia MS, Dirk F. PhD, Atif J. MD,